HOME › DRUGS › RALOXIFENE
ACTIVE SUBSTANCE / INN

RALOXIFENE

Brand name(s): Evista, Optruma, Raloxifene Teva
EMA LISTED
AUTHORISED
Osteoporosis, Postmenopausal
ACTIVE SUBSTANCE
Raloxifene
REGULATORS
EMA
SPONSORS / MAH
Substipharm, Teva B.V., Eli Lilly Nederland B.V.
TOTAL APPLICATIONS
3
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OptrumaEli Lilly Nederland B.V.Authorised05/08/1998Osteoporosis, Postmenopausal
EvistaSubstipharmAuthorised05/08/1998Osteoporosis, Postmenopausal
Raloxifene TevaTeva B.V.Authorised29/04/2010Osteoporosis, Postmenopausal

FULL INTELLIGENCE ON RALOXIFENE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →